Date published: 2025-12-7

1-800-457-3801

SCBT Portrait Logo
Seach Input

TGFβ3 Inhibitors

Common TGFβ3 Inhibitors include, but are not limited to LY2157299 CAS 700874-72-2, SB 431542 CAS 301836-41-9, Pirfenidone CAS 53179-13-8, TGF-β RI Kinase Inhibitor V CAS 627536-09-8 and GW788388 CAS 452342-67-5.

TGFβ3 inhibitors constitute a distinct chemical class of compounds designed to intricately regulate the signaling pathways associated with Transforming Growth Factor Beta 3 (TGFβ3). As a member of the TGF-β superfamily of cytokines, TGFβ3 plays a critical role in numerous cellular processes, most notably in embryonic development, wound healing, and tissue repair. The inhibitors within this class are precisely engineered to interact with specific components of the TGFβ3 signaling cascade, including its receptors or downstream effectors. By engaging in these interactions, TGFβ3 inhibitors proficiently disrupt the binding and activation of TGFβ3 to its receptors, thereby impeding the subsequent intracellular signaling events that would otherwise ensue. The primary function of TGFβ3 inhibitors revolves around modulating TGFβ3 signaling, which, in turn, offers researchers a powerful and versatile tool to meticulously explore the intricacies of TGFβ3-mediated biological responses. These inhibitors are instrumental in deciphering the molecular mechanisms underlying TGFβ3's regulatory role in various physiological and pathological contexts. By selectively inhibiting TGFβ3, researchers gain a comprehensive understanding of its contribution to cellular processes, ranging from embryogenesis to tissue remodeling. Furthermore, studying TGFβ3 inhibitors helps elucidate the complex interplay between TGFβ3 and other essential cellular pathways, shedding light on the multifaceted regulatory functions of this cytokine within the cellular milieu.

The significance of TGFβ3 inhibitors lies in their ability to pave the way for innovative research endeavors. Their utility lies in the elucidation of fundamental biological processes, thereby expanding our knowledge of TGFβ3's involvement in diverse cellular contexts. As researchers continue to delve into the intricacies of TGFβ3 signaling, TGFβ3 inhibitors remain pivotal in advancing our understanding of this crucial cytokine and its profound influence on cellular responses.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

LY2157299

700874-72-2sc-391123
sc-391123A
5 mg
10 mg
$209.00
$352.00
3
(1)

LY2157299 is a small molecule inhibitor of the TGF-β receptor I kinase (ALK5).

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$80.00
$212.00
$408.00
48
(1)

SB431542 is a selective small molecule inhibitor of the TGF-β type I receptor (ALK5). It has been widely used in research to block TGF-β signaling and understand its role in various cellular processes.

Pirfenidone

53179-13-8sc-203663
sc-203663A
10 mg
50 mg
$100.00
$408.00
6
(1)

While it primarily inhibits TGF-β1, Pirfenidone has also been reported to have some inhibitory effects on TGF-β

TGF-β RI Kinase Inhibitor V

627536-09-8sc-203294
2 mg
$86.00
3
(1)

TGF-β RI Kinase Inhibitor V is another small molecule inhibitor targeting the TGF-β receptor I kinase (ALK5). It has been studied for its potential anti-fibrotic and anti-cancer properties.

GW788388

452342-67-5sc-363544
sc-363544A
5 mg
25 mg
$95.00
$384.00
(0)

GW788388 is a selective small molecule inhibitor of the TGF-β type I receptor kinase (ALK5) and has been explored in some studies for fibrotic diseases.

LY2109761

700874-71-1sc-396262
sc-396262A
1 mg
5 mg
$87.00
$270.00
9
(1)

LY2109761 is a small molecule inhibitor of both TGF-β receptor I (ALK5) and the activin receptor-like kinase 4 (ALK4). It has been investigated for its potential anti-tumor effects.

LY-333,531 Hydrochloride

169939-93-9sc-364215
sc-364215A
1 mg
5 mg
$92.00
$281.00
6
(2)

While it was initially developed as a protein kinase C (PKC) inhibitor, LY333531 has also been found to inhibit TGF-β2-induced effects in certain contexts.

Nilotinib

641571-10-0sc-202245
sc-202245A
10 mg
25 mg
$205.00
$405.00
9
(1)

Primarily known as a tyrosine kinase inhibitor targeting Bcr-Abl in leukemia, Nilotinib has also been reported to have inhibitory effects on TGF-β2.

Tranilast

53902-12-8sc-200389
sc-200389A
sc-200389B
sc-200389C
10 mg
50 mg
1 g
5 g
$30.00
$101.00
$277.00
$959.00
2
(1)

Tranilast is an anti-allergy drug that has been found to have inhibitory effects on TGF-β2-induced fibrosis.